U.S. Building Stock News

Revolution Medicines (NasdaqGS:RVMD) sent a cease and desist letter to Erasca, alleging patent infringement and trade secret misappropriation around RAS inhibitor programs. The company advanced daraxonrasib’s regulatory path and released new Phase 3 data, ahead of a high profile ASCO Plenary Presentation. The combination of legal action and clinical progress raises fresh questions about future market exclusivity, licensing potential, and competitive positioning in RAS targeted...

Coupang (CPNG) opened Q1 2026 with revenue of about US$8.5b and a basic EPS loss of US$0.15, alongside a trailing twelve month basic EPS loss of US$0.09 on revenue of roughly US$35.1b. This keeps the focus firmly on how efficiently that scale is translating into earnings. Over recent quarters the company has seen revenue move from about US$7.9b in Q1 2025 to US$9.3b in Q3 2025 before landing at US$8.5b this quarter. Over the same period, quarterly basic EPS has swung from a profit of US$0.06...

Wolfspeed recently reported fiscal third-quarter 2026 results showing sales of US$150.2 million and a net loss of US$119.9 million, while also refinancing debt by raising about US$475.9 million and redeeming its Senior Secured Notes due 2030. Alongside strengthening its balance sheet, the company is pivoting its silicon carbide business toward AI data centers and industrial applications, supported by new high-voltage product launches and leadership additions to oversee legal, compliance, and...

In late April 2026, Meta Platforms completed a series of US$25.00 billion senior unsecured bond issues across multiple maturities while also reporting first‑quarter revenue of US$56.31 billion and net income of US$26.77 billion, supported by AI‑enhanced advertising performance. At the same time, Meta sharply raised its 2026 capital expenditure guidance into the roughly US$125.00–US$145.00 billion range to fund AI infrastructure and large data center projects such as the planned...

Arbor Realty Trust recently reported quarterly results after previously beating expectations despite a year-on-year revenue decline, while analysts still project further pressure on earnings and revenue. Analyst views remain mixed, with some emphasizing earnings estimate cuts and non-performing loan work-outs, while others still highlight operational progress and capital redeployment efforts. Next, we’ll examine how this mixed analyst backdrop ahead of Arbor Realty Trust’s earnings update...

Lear Corporation (NYSE:LEA) reports stronger-than-expected international revenue, with outperformance in Europe, Africa, and South America. The company announces expanded business with major automakers, including General Motors and Audi. Lear highlights accelerated growth with Chinese automakers, pointing to a changing geographic revenue mix. Lear, a global supplier of automotive seating and electrical systems, sits at the center of key shifts in the auto industry as customers invest in new...

Core Scientific (NasdaqGS:CORZ) has agreed to acquire Polaris DS LLC as part of a plan to expand its Muskogee, Oklahoma data center campus. The Muskogee project is aimed at adding power capacity focused on high-density colocation and AI oriented workloads. This move reflects a greater focus on AI and high-performance computing infrastructure alongside Core Scientific's existing Bitcoin mining operations. Core Scientific, trading at $24.63, has delivered a 25.9% return over the past week and...

Aurinia Pharmaceuticals Inc. has reported its first-quarter 2026 results, with revenue rising to US$77.71 million and net income to US$34.36 million, lifting diluted earnings per share from continuing operations to US$0.25 compared with US$0.16 a year earlier. The quarter underscored the growing commercial role of LUPKYNIS in lupus nephritis, as higher sales and improved gross margins helped Aurinia deliver stronger profitability while reaffirming its 2026 revenue guidance. Next, we’ll...

Considering whether Medtronic stock is starting to look like value, or if the recent share price still leaves limited upside for new buyers. Medtronic closed at US$77.60, with recent total returns showing a 2.2% loss over 7 days, a 10.1% loss over 30 days, and a 19.2% loss year to date, adding to a 3.7% loss over 1 year, 4.3% loss over 3 years, and 26.6% loss over 5 years. Recent coverage has continued to focus on Medtronic as a major global medical technology company, highlighting how it is...

Phoenix Asia Holdings (PHOE) has drawn fresh attention after recent trading, with the stock last closing at $28.60. Investors are weighing its substructure construction focus in Hong Kong against recent short term share price moves. See our latest analysis for Phoenix Asia Holdings. The recent 1 day share price return of 39.14% decline contrasts sharply with the 7 day share price return of 83.92% and the year to date share price return of 76.11%. The 1 year total shareholder return is very...

How Goldman Sachs Group (GS) Is Positioned After Recent Performance Goldman Sachs Group (GS) has drawn fresh attention after recent share price gains, with the stock up 2.0% over the past day, 3.5% over the past week and 8.2% over the past month. That move comes alongside a 5.3% total return over the past 3 months and 73.4% over the past year, putting the current share price at $937.35 and raising questions about how the company’s fundamentals line up with recent returns. See our latest...

First Mid Bancshares recently reported first-quarter 2026 results showing higher net interest income of US$70.79 million and net income of US$26.33 million compared with a year earlier, while also announcing ongoing leadership succession, a regular US$0.25 dividend, and completion of a modest share repurchase program. An interesting angle for investors is that incoming CEO Matthew K. Smith, a long-time finance leader and former CFO, will combine board, risk committee, and executive...

Investors may be wondering if Soleno Therapeutics at around US$52.94 is priced attractively after its past swings, or if most of the opportunity is already reflected in the stock. The share price shows a mixed picture, with returns of 0.3% over 7 days, 1.3% over 30 days, 12.2% year to date, a 29.1% decline over the last year, and a very large gain over 3 years that is more than 10x. Recent headlines around Soleno Therapeutics have focused on its progress as a clinical stage biopharmaceutical...

Context for Mattel after a weak three month stretch Mattel (MAT) has drawn fresh attention after a weak past 3 months for the stock, with a negative 28.6% total return, in contrast with modest gains over the past month and week. See our latest analysis for Mattel. At a share price of $15.08, Mattel’s short-term momentum has increased with a 1 month share price return of 3.93%, but the 1 year total shareholder return of 13.48% still indicates weaker longer-term performance. If you are...

Kimco Realty (KIM) is back on investors’ radar after Q1 2026 results, a guidance update, and dividend news put a fresh spotlight on the real estate investment trust’s earnings power and income profile. See our latest analysis for Kimco Realty. At a share price of $23.80, Kimco Realty has seen a 5.97% 1 month share price return and 18.64% year to date share price return. Its 1 year total shareholder return of 20.81% and 3 year total shareholder return of 51.72% suggest momentum has been...

Wondering if Eversource Energy at around US$68.52 is offering you fair value today, or if the recent run has already priced in most of the opportunity? The stock is roughly flat over the past week with a 0.3% slip and a 1.3% decline over 30 days, yet it has returned 15.2% over the last year and is up 0.7% year to date. Recent coverage around utilities has kept attention on how regulated players manage costs, investment needs and balance sheet strength. All of these factors feed into how...

QCR Holdings (QCRH) has drawn fresh attention after a recent share price move, with the stock closing at $91.86. Investors are weighing this level against the company’s fundamentals and recent return profile. See our latest analysis for QCR Holdings. The recent 1 day share price return of 0.45% and 1 month share price return of 4.96% sit alongside a 1 year total shareholder return of 39.84%. This suggests momentum has been generally constructive even with a softer 3 month patch. If you are...

Energy Vault Holdings, Inc. ( NYSE:NRGV ) missed earnings with its latest first-quarter results, disappointing...

A week ago, Rockwell Automation, Inc. ( NYSE:ROK ) came out with a strong set of quarterly numbers that could...

In April and early May 2026, BlackRock expanded its Aladdin platform by integrating enhanced private credit analytics and data from Preqin, aiming to provide investors with a more unified, transparent view of private credit markets. This move underlines how BlackRock is leaning on its technology stack to deepen its role in private markets, an area many institutional investors increasingly scrutinize for risk and portfolio construction decisions. We’ll now examine how BlackRock’s enhanced...

Silicon Motion Technology Corporation recently reported first-quarter 2026 results, with sales rising to US$342.11 million and net income to US$66.8 million, and issued second-quarter guidance pointing to further revenue growth and operating margins between 19.8% and 21.1%. The company also reaffirmed its annual dividend of US$2.00 per ADS, underlining a continued commitment to shareholder returns alongside expanding demand for its controllers used in AI and enterprise storage...

Q1 earnings highlight a narrower loss N-able (NABL) reported first quarter 2026 earnings with a net loss of US$615,000, compared with a net loss of US$7.16 million a year earlier, drawing fresh attention to the stock. See our latest analysis for N-able. The earnings update comes after a mixed share price stretch, with a 10.17% 1 month share price return, a 27.26% year to date share price decline, and a 25.63% 1 year total shareholder return loss, suggesting momentum has been weak despite...

ProFrac Holding Corp. has reported its first-quarter 2026 results, with sales of US$449.6 million versus US$600.3 million a year earlier and a net loss of US$83.5 million compared with US$17.5 million previously. The sharp year-over-year widening of ProFrac’s net loss, despite still sizable quarterly revenue, raises fresh questions about cost structure and profitability trajectory. We’ll now examine how ProFrac’s weaker first-quarter revenue and larger net loss may influence its previously...

Wondering if ONE Gas at around US$86 is offering good value or if the easy gains are already behind it? This breakdown will help you frame the stock through several valuation lenses. The stock is up 11.1% year to date and 9.3% over the last year, despite 7 day and 30 day returns of 1.8% and 2.9% declines. Recent coverage has focused on ONE Gas within the Gas Utilities sector. It has drawn attention to how investors are weighing regulated utility stability against changing expectations for...